Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04954222 · ClinicalTrials.gov registry record
Recovery of Respiratory System in COVID-19 Patients
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 80
- Enrollment target
NCT04954222: Completed study, sponsored by Mayo Clinic.
NCT04954222 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04954222 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of the clinical course of treatment as well as long-term symptoms of COVID-19 on respiratory function, exercise capacity, and quality of life.
Primary Outcome
change in diffusing capacity of the lungs for carbon monoxide and its components
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2024-01-08 |
What the finished NCT04954222 record still lists
NCT04954222 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04954222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04954222 about?
NCT04954222 is a clinical study titled "Recovery of Respiratory System in COVID-19 Patients". The purpose of this study is to determine the effects of the clinical course of treatment as well as long-term symptoms of COVID-19 on respiratory function, exercise capacity, and quality of life.
What is the current status of trial NCT04954222?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2022-02-14. Estimated completion is 2024-01-08.
Who is sponsoring clinical trial NCT04954222?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI